{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:27:00Z","timestamp":1761535620334,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1439,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/jth.14308","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T23:30:25Z","timestamp":1538782225000},"page":"2462-2470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin\u2010based trigger"],"prefix":"10.1016","volume":"16","author":[{"given":"V.","family":"Taune","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Skeppholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"\u00c5gren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gryfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wikman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Van Ryn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wall\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14308_bb0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14308_bb0015","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14308_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians","volume":"16","author":"Douxfils","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long\u2010Term Anticoagulation Therapy (RE\u2010LY) randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"key":"10.1111\/jth.14308_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation","volume":"131","author":"Graham","year":"2015","journal-title":"Circulation"},{"key":"10.1111\/jth.14308_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2013 full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14308_bb0040","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00228-013-1550-4","article-title":"Evaluation of coagulation assays versus LC\u2010MS\/MS for determinations of dabigatran concentrations in plasma","volume":"69","author":"Antovic","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jth.14308_bb0045","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.thromres.2014.06.016","article-title":"On the monitoring of dabigatran treatment in \u2018real life\u2019 patients with atrial fibrillation","volume":"134","author":"Skeppholm","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14308_bb0050","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/jth.12308","article-title":"Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross\u2010sectional pharmacodynamic study based on peak and trough plasma levels","volume":"11","author":"Hawes","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0055","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.amjcard.2013.08.027","article-title":"Meta\u2010analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors","volume":"112","author":"Artang","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.14308_bb0060","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jth.12702","article-title":"Determination of dabigatran, rivaroxaban and apixaban by ultra\u2010performance liquid chromatography \u2013 tandem mass spectrometry (UPLC\u2010MS\/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants","volume":"12","author":"Schmitz","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1309\/AJCPRNUMI4PVSJ7Q","article-title":"Performance of various laboratory assays in the measurement of dabigatran in patients receiving therapeutic doses: a prospective study based on peak and trough plasma levels","volume":"141","author":"Gosselin","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.14308_bb0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00101-012-2091-4","article-title":"Effect of rivaroxaban on blood coagulation using the viscoelastic coagulation test ROTEM","volume":"61","author":"Casutt","year":"2012","journal-title":"Der Anaesthesist"},{"key":"10.1111\/jth.14308_bb0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MBC.0000000000000203","article-title":"Results of rotational thromboelastometry, coagulation activation markers and thrombin generation assays in orthopedic patients during thromboprophylaxis with rivaroxaban and enoxaparin: a prospective cohort study","volume":"26","author":"Oswald","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.14308_bb0080","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.thromres.2014.08.006","article-title":"Measuring the activity of apixaban and rivaroxaban with rotational thrombelastometry","volume":"134","author":"Adelmann","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14308_bb0085","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/STROKEAHA.113.004016","article-title":"Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke","volume":"45","author":"Bowry","year":"2014","journal-title":"Stroke"},{"key":"10.1111\/jth.14308_bb0090","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5858\/arpa.2014-0170-OA","article-title":"Use of thromboelastography (TEG) for detection of new oral anticoagulants","volume":"139","author":"Dias","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/jth.14308_bb0095","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1160\/TH12-04-0222","article-title":"The ex\u00a0vivo reversibility of dabigatran\u2010induced whole\u2010blood coagulopathy as monitored by thromboelastography: mechanistic implications for clinical medicine","volume":"108","author":"Davis","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0100","first-page":"1615","article-title":"Global coagulation tests: their applicability for measuring direct factor\u00a0Xa\u2010 and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate","volume":"52","author":"Dinkelaar","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.14308_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1515\/cclm-2013-0936","article-title":"Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests","volume":"52","author":"Eller","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.14308_bb0110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1160\/TH14-08-0712","article-title":"Reversal of dabigatran anticoagulation ex\u00a0vivo: porcine study comparing prothrombin complex concentrates and idarucizumab","volume":"113","author":"Honickel","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0115","doi-asserted-by":"crossref","first-page":"e3037","DOI":"10.1097\/MD.0000000000003037","article-title":"Comparative assessment of the anticoagulant activity of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation: a noninterventional study","volume":"95","author":"Tsantes","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/jth.14308_bb0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2016.01.148","article-title":"Thrombelastography detects dabigatran at therapeutic concentrations in\u00a0vitro to the same extent as gold\u2010standard tests","volume":"208","author":"Solbeck","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.14308_bb0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11239-017-1477-1","article-title":"Determination of non\u2010vitamin\u00a0K oral anticoagulant (NOAC) effects using a new\u2010generation thrombelastography TEG 6s system","volume":"43","author":"Bliden","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.14308_bb0130","first-page":"989","article-title":"Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban","volume":"111","author":"Herrmann","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11239-013-0933-9","article-title":"Dabigatran\u2010associated subdural hemorrhage: using thromboelastography (TEG((R))) to guide decision\u2010making","volume":"37","author":"Neyens","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.14308_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.thromres.2018.02.141","article-title":"Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration","volume":"164","author":"Comuth","year":"2018","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14308_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12959-017-0160-2","article-title":"Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation","volume":"16","author":"Henskens","year":"2018","journal-title":"Thromb J"},{"key":"10.1111\/jth.14308_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365513.2017.1408138","article-title":"The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG((R))), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT)","volume":"78","author":"Solbeck","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1111\/jth.14308_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ijlh.12744","article-title":"Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM)","volume":"40","author":"Seyve","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.14308_bb0160","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/ALN.0000000000001856","article-title":"Reversing dabigatran anticoagulation with prothrombin complex concentrate versus idarucizumab as part of multimodal hemostatic intervention in an animal model of polytrauma","volume":"127","author":"Honickel","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.14308_bb0165","first-page":"Cd007871","article-title":"Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding","volume":"8","author":"Wikkelso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.14308_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2017.03.018","article-title":"Whole blood coagulation assays ROTEM and T\u2010TAS to monitor dabigatran treatment","volume":"153","author":"Taune","year":"2017","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14308_bb0175","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.110.004424","article-title":"Dabigatran etexilate: a new oral thrombin inhibitor","volume":"123","author":"Hankey","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.14308_bb0180","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","article-title":"A specific antidote for dabigatran: functional and structural characterization","volume":"121","author":"Schiele","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.14308_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE\u2010LY Trial (Randomized Evaluation of Long\u2010Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.14308_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jth.13178","article-title":"Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure","volume":"14","author":"Douketis","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000470622","article-title":"In\u00a0vitro and ex\u00a0vivo measurement of prophylactic dabigatran concentrations with a new ecarin\u2010based thromboelastometry test","volume":"44","author":"Korber","year":"2017","journal-title":"Transfus Med Hemother"},{"key":"10.1111\/jth.14308_bb0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/EJA.0b013e328363171a","article-title":"Validation of rotational thromboelastometry during cardiopulmonary bypass: a prospective, observational in\u2010vivo study","volume":"31","author":"Gronchi","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"10.1111\/jth.14308_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1538-7836.2007.02319.x","article-title":"Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography","volume":"5","author":"Rugeri","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14308_bb0210","first-page":"Cd010438","article-title":"Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding","volume":"2","author":"Hunt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/jth.14308_bb0215","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00000542-200005000-00011","article-title":"Citrate storage affects Thrombelastograph\u00ae analysis","volume":"92","author":"Camenzind","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.14308_bb0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mbc.0000169225.31173.19","article-title":"Multi\u2010centre investigation on reference ranges for ROTEM thromboelastometry","volume":"16","author":"Lang","year":"2005","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14308","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202952X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202952X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14308\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:22:08Z","timestamp":1761535328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362202952X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S153878362202952X"],"URL":"https:\/\/doi.org\/10.1111\/jth.14308","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin\u2010based trigger","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Wall\u00e9n et. al. Journal of Thrombosis and Haemostasis. International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}